By using the intravoxel incoherent motion (IVIM) model, the diffusion-related coefficient (D) and the
. To address this issue, functional imaging modalities offer more advantages by providing both structural and physiological or even metabolic information for cervical cancers. For instance, dynamic contrast-enhanced (DCE) MR imaging has proven useful in predicting better long-term treatment outcomes in cervical cancers with higher tissue permeability 11 , yet this method involves the use of exogenous gadolinium contrast agents. Diffusion-weighted (DW) imaging can generate apparent diffusion coefficient (ADC) values, whose early change rate after therapy also has predictive potential in cervical cancers treated with CCRT [12] [13] [14] .
As an expansion of DW imaging, IVIM MR imaging provides both pure diffusion and perfusion-related incoherent microcirculation information by using an increased number of b values 15 . IVIM-generated parameters have proven effective in differentiating cervical cancers from benign lesions and in monitoring therapeutic changes during CCRT 16 . However, the role of IVIM MR imaging in predicting the long-term prognosis of cervical cancers after CCRT has not previously been reported.
Therefore, the purpose of this study was to assess whether IVIM-derived parameters taken before and during early therapy are effective imaging biomarkers in predicting long-term outcomes in patients with advanced cervical cancers treated with CCRT.
Results
Predictive value of clinical characteristics of patients and their correlation with IVIM parameters. No significant differences were observed in age between the different groups, with p values of 0.986.
Moreover, different FIGO stages (below FIGO III versus FIGO III and above) showed no significant correlation with prognosis (p = 0.690).
All the IVIM parameters except D* showed a significant positive relationship with different follow-up time points, but the age and FIGO stage of patients had weak associations with the parameters (Table 1) .
Predictive value of short-term outcome evaluated with RECIST. Five patients classified as CR ultimately had poor prognosis (25.00%, 3 deaths and 2 recurrences), and 6 (60.00%) classified as PR ultimately responded well later (Table 2) . Hence, the short-term outcome showed a sensitivity of 71.43% and a specificity of 44.44% in predicting the long-term prognosis. Predictive values of morphological changes during the CCRT. A morphological response was recognized in all patients along with the therapy (Fig. 1) , and a greater tumour size decrease (at time point 1 vs. 2 and at time point 1 vs. 3, p = 0.027 and 0.018, respectively) was observed in patients with good long-term outcomes than in those with poor outcomes. ROC analysis showed no predictive power in the change rate of maximum diameter (time point 1 vs. 2) as p = 0.067, and with a change rate of maximum diameter (time point 1 vs. 3) ≥ 58.31%, the sensitivity and specificity in predicting good outcome were 0.810 and 0.667, respectively (area under ROC curve, AUC = 0.751, p = 0.032) (Fig. 2) . Dynamic changes in maximum diameters of cervical cancers treated with concurrent chemoradiotherapy (CCRT) in patients with good and poor prognosis, respectively. Significant decreases were observed within both groups, and no significant differences were observed between them. 
Discussion
We demonstrated the feasibility of using IVIM parameters, especially the f and ADC IVIM values, to predict long-term prognosis in patients with advanced cervical cancer treated with CCRT, which has never been reported previously.
Predictive value of short-term outcomes evaluated with RECIST. The long-term prognosis was quite different from the short-term outcome evaluated with RECIST, with a sensitivity of 71.43% and a specificity of 44.44% in our study. Vincens et al. 17 have reported that conventional MR imaging after treatment (median interval: 35 days) shows a sensitivity of 80% and a specificity of 55% in predicting residual disease of cervical cancers treated with CCRT, a result in line with our findings. Therefore, the short-term outcome evaluated with RECIST had a high false positive rate and a moderate false negative rate in predicting long-term outcomes for patients with cervical cancers treated with CCRT. This might because the radiation changes (inflammation, edema, and capillary hypervascularity) during the therapy may misleading the accurate differentiation between residual tumor and therapy induced changes.
Predictive ability of tumour size. Larger pretreatment tumour sizes are considered to be related to poorer prognosis in patients with cervical cancers 5, 18 . However, we did not detect any significant difference of baseline maximum diameter of the lesion between patients with good and poor prognoses in this study, possibly because of the small sample size. Nevertheless, the pretreatment index contained little information regarding the therapeutic response; hence, its predictive value was compromised for evaluating patients undergoing treatment.
After the therapy started, the tumour size of the cervical cancer continued to decrease, and the good responders showed a greater rate of decrease than the poor responders. At time point 3 (4 weeks after the initiation of . However, evaluation of the tumour size was less effective and provided less rapid results than the IVIM parameters, as discussed below.
Predictive ability of the f value. At time point 3, a lower f value of cervical cancer predicted poor prognosis with an AUC of 0.820. The f value is known as the vascular volume fraction of the voxel. A lower f value might indicate lower blood supply and hypoxic status of the tumour tissues, which are involved in local treatment failure after radiation therapy, a high incidence of regional or distant metastases, and poor disease-free survival rates in multiple solid tumours, including cervical cancer [20] [21] [22] [23] . However, Hauser et al. 24 have reported that a high initial f value is related to poor prognosis in patients with head and neck squamous cell carcinomas treated with radiotherapy in combination with chemotherapy and/or immunotherapy, possibly because of the different tumour types included in our study. In addition, Christine et al. and Yuh et al. have reported that cervical cancers with low perfusion derived by DCE MR imaging are likely to be resistant to radiation treatment as well as to have a high probability of developing metastases 25, 26 ; these results may indirectly support our findings. 14 . Moreover, in the same study, a mid-treatment ADC value less than 1.40 × 10 −3 mm 2 /s has been found to be associated with adverse outcomes, similarly to our results (cut-off value of ADC IVIM at time point 2, 1.29 × 10 −3 mm 2 /s). However, the pure diffusion coefficient D value demonstrated no significant power, thus indicating that perfusion effects might be an essential part of predicting treatment response. Moreover, the ADC DWI value also was unable to predict long-term prognosis, probably because of the measurement error, owing to the limited number of b values.
According to our results, the IVIM sequence provided more diversified as well as more powerful parameters in predicting the long-term prognosis of advanced cervical cancer at early stages of CCRT. The IVIM parameters allow for earlier (two weeks after the initiation of CCRT) and more accurate (AUC of 0.857) prediction of long-term prognosis. The greater performance of IVIM may be a result of the multifunctional information that it provides. Furthermore, the IVIM parameters showed a significant positive relationship with different follow-up time points, but the age and FIGO stage of patients had weak associations with the parameters. Thus, IVIM parameters provide a good indication of the therapy-induced changes in tissue, which is more related to the treatment outcome than to the baseline clinical characteristics of the tumour.
Limitations
There are several limitations in this study. First, the sample size was relatively small, and the pathological type of cervical cancers was simple (all squamous cell carcinomas) and hence might not be broadly representative. But every patient in our study received 3 MR examinations leading to a triple data size, which can help reduce the bias. Second, the follow-up time was relatively short, and longer follow ups are needed for confirmation. Third, multiple b values (14, 0∼1000 s/mm 2 ) were arbitrarily selected for IVIM imaging, which required some technical optimization. Fourth, for several good responders, there was distinct size shrinkage, which made it difficult to exactly define the ROI. All the above issues require further investigation.
Conclusion
IVIM-derived parameters have great potential for predicting long-term outcomes in patients with cervical cancers treated with CCRT. These parameters were superior to tumour morphologic information in predictive value. As a noninvasive technology that does not use exogenous contrast agents, IVIM MR imaging may be used as a routine radiologic procedure in clinical practice. If the patients at higher risk can be identified early, they could be offered treatment intensification, thus improving long-term survival. 
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Materials and Methods
Patients. This study was approved by the ethics committee of the Institutional Review Board of Nanjing Drum Tower Hospital, and written informed consent was obtained from all patients. All experiments were performed in accordance with relevant guidelines and regulations. Patients with histologically proven untreated cervical cancer (FIGO IIA ∼ IVB) who were scheduled to undergo CCRT, were prospectively included. The exclusion criteria were age below 18 years and contraindications for MR scanning (such as pacemaker implantation, artificial cochlea, or claustrophobia disorder) or CCRT (such as pregnancy, severe hepatic and renal dysfunction, or drug allergy). From January 2014 to August 2016, 30 consecutive female patients with histologically confirmed uterine cervical cancers (all squamous cell carcinomas) were prospectively included. The median age was 51.1 years (range: 24∼76 years), and detailed characteristics of the patients are listed in Table 2 .
All patients were treated with CCRT consisting of five weeks of external beam radiotherapy (EBRT) at a dose of 1.8∼2.0 Gy daily to a total dose of approximately 45 Gy and 3 weeks' intracavitary brachytherapy with a total dose of 30∼40 Gy at point A. The definition of point A followed the American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix 27 . In addition, weekly nedaplatin or bi-weekly nedaplatin plus paclitaxel/docetaxel was concomitantly administered. The therapeutic regimens were adjusted according to the health conditions of individual patients. 
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where S b represents the mean signal intensity with diffusion gradient b, and S 0 represents the mean signal intensity in pixels without diffusion gradient. f is the microvascular volume fraction, D is the pure diffusion coefficient, and D* is the perfusion-related incoherent microcirculation. Considering that D* is much greater than D, the effects of D* on the signal decay at large b values (>200 s/mm 2 ) can be ignored. Thus, at higher b values, Eq. (2) can be simplified into a Linear fit equation by which D can be estimated:
Based on the value of D calculated using Eq. (3), f and D* values can then be calculated by using a partially constrained nonlinear regression algorithm based on Eq. (2). With reference to other MR sequences, the axial DW or IVIM image that manifested the largest area of the tumour was selected, as well as the two adjacent slices above and below it. Regions of interest (ROIs) were Scientific REPORTS | 7: 11635 | DOI:10.1038/s41598-017-11988-2 manually drawn to cover as large an area of the solid part of the tumour as possible (mean: 934.12 mm 2 , range: 86.52∼2489.30 mm 2 ), carefully excluding the macroscopic necroses, large vessels and areas with motion or magnetic susceptibility artefacts. The ROIs were copied to exactly the same locations on the ADC DWI , ADC IVIM , D, f and D* maps and the mean value from each ROI was obtained. The average value of the three slices and mean values from the two radiologists were calculated as the final results. If no residual tumour was observed after the treatment, ROIs were placed in the region where the lesion was initially located, and the maximum diameter was recorded as 0 cm. The change rate of a certain parameter was determined as: (time point A vs. B) = (value B − value A )/value A × 100%.
Short-term and long-term outcome assessment. The short-term outcome was assessed one month after conclusion of the entire course of therapy by using morphological MR scanning according to RECIST as follows: (1) complete response (CR) was concluded if no residual tumour could be seen on the MR images; (2) partial response (PR) was concluded if the largest diameter of the residual tumour was 30% less than the original size or more; (3) progress of disease (PD) was concluded if there was an at least 20% increase in the longest diameter of the tumour compared with the pretreatment size; (4) the disease was considered as stable (SD) if there was neither a decrease sufficient to qualify for PR nor an increase sufficient to qualify for PD. According to the above criteria, 20 patients were classified as CR, and the remaining 10 were classified as PR; no PD or SD were defined.
Follow up was performed 1 month and 3 months after conclusion of CCRT and every 6 months thereafter until tumour recurrence or death. The long-term treatment outcome depended on the nearest follow-up with clinical (physical examination or pap smear) or imaging (CT and/or MR imaging) evidence: patients with complete remission was defined as having good prognosis, and patients whose outcomes were death, recurrence or sustained disease (patients classified as PR both after short-term and long-term follow-up) were defined as having poor prognosis. During a median follow up of 24 months (range: 10∼34 months), 21 patients had a good prognosis whereas the remaining 9 patients had a poor prognosis (5 deaths, 3 local recurrences, and 1 sustained disease) ( Table 2 ).
Statistical analyses.
Statistical analyses were performed with SPSS 16.0 (SPSS Inc., Chicago, IL). All quantitative values in normal distribution are presented as the mean ± standard deviation (SD). Multiple linear regression was used to assess interactions between clinical characteristics and the IVIM parameters. Repeated measurements analysis of variance (ANOVA) was used for the overall differences of each parameter between different time points as well as different groups. A paired samples t-test was performed to detect significant changes in IVIM-related parameters and tumour size changes during CCRT. A chi-square test was performed to determine the relationship between the short-term outcome and the long-term treatment outcome, and the relationship between different FIGO stages and the long-term treatment outcome. Receiver operating characteristic (ROC) analysis was performed for the predictive value of parameters with significant differences between different prognoses. The intraclass correlation coefficient (ICC) was calculated to evaluate interobserver agreement in the measurement of IVIM-related parameters. Two-tailed p values less than 0.05 were considered statistically significant.
Data Availability. The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
